Evidence map›Paper›PMID 29415661›Full record

ArticleBMC cancer2018

Diethylnitrosamine induces lung adenocarcinoma in FVB/N mouse.

Zsolt Mervai, Krisztina Egedi, Ilona Kovalszky, Kornélia Baghy

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Characterization of anCancers · 2023
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Zsolt MervaiDepartment of Pathology and Experimental Cancer Research, Budapest, Hungary.
Krisztina EgediDepartment of Pathology and Experimental Cancer Research, Budapest, Hungary.
Ilona KovalszkyDepartment of Pathology and Experimental Cancer Research, Budapest, Hungary.
Kornélia BaghyDepartment of Pathology and Experimental Cancer Research, Budapest, Hungary. baghy.kornelia@med.semmelweis-univ.hu.ORCID 0000-0002-5323-2775
HUN-REN Institute of Experimental Medicine · HUSemmelweis University · HU

Funding

Országos Tudományos Kutatási Alapprogramok 100904Országos Tudományos Kutatási Alapprogramok 105763
6 · The paper itself

Abstract

backgroundDiethylnitrosamine is a well known carcinogen that induces cancers of various organs in mice and rats. Using FVB/N mouse strain, here we show that diethylnitrosamine induces primarily lung adenocarcinomas with modest tumor development in the liver, offering a new model to study chemical carcinogenesis in the lung.

methodsAnimals were exposed to a single high dose of diethylnitrosamine, and more than 70% of the mice developed lung cancer. To obtain a new transplantable tumor line, pieces of primary tumors were inoculated and maintained subcutaneously in the same mouse strain. We used immunohistochemistry to characterize the tumor for main lung adenocarcinoma markers. We searched for mutations in KRAS exon 2 and EGFR exon 19, 21 with Sanger sequencing. We also compared the normal lung tissue with the diethylnitrosamine induced primary adenocarcinoma, and with the subcutaneously maintained adenocarcinoma using Western blot technique for main cell cycle markers and to identify the main pathways.

resultsPrimary and subcutaneous tumors express cytokeratin-7 and thyroid transcription factor-1, markers characteristic to lung adenocarcinoma. In addition, no mutations were found in the hot spot regions of KRAS and EGFR genes. We found high mTOR activation, but the level of p-Akt Ser473 and p-Akt Thr308 decreased in the tumorous samples.

conclusionsWe established a new lung adenocarcinoma model using FVB/N mouse strain and diethylnitrosamine. We believe that this new model system would be highly useful in lung cancer research.

Indexed as

Disease Models, AnimalAdenocarcinomaAnimalsBase SequenceBiomarkers, TumorDiethylnitrosamineErbB ReceptorsFemaleHumansKeratin-7LungLung NeoplasmsMaleMiceMutationProto-Oncogene Proteins p21(ras)Biomarkers, TumorDiethylnitrosamineErbB ReceptorsKeratin-7KRAS protein, humanNkx2-1 protein, mouseProto-Oncogene Proteins p21(ras)Thyroid Nuclear Factor 1DiethylnitrosamineLung cancerMouse modelNSCLCTumorigenesis

Identifiers

PMID29415661
PMCPMC5803903
OpenAlexW2799442527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.